Solid solutions of aripiprazole (APZ) and its active metabolite, dehydro-aripiprazole (dAPZ),
have been prepared as free form (neat or nonsolvated), hydrated, or alcohol-solvated …

The polymorphic (crystal systems for which a substance can exist in structures defined by
different unit cells, and where each of the forms has the same elemental composition) and …

A new crystalline polymorph (Form VIII) of the antidepressant drug aripiprazole has been
discovered, resulting from a previously unknown enantiotropic phase transition from Form II …

Crystal form exploration of dehydro-aripiprazole (dAPZ), the active metabolite of the
antipsychotic drug aripiprazole (APZ), elucidated five polymorphs (I, II, III, IV, and V), two …

Many formulation and manufacturing processes can lead to morphological and crystalline
transitions in many polycrystalline drugs, changing the properties of active pharmaceutical …

We aimed to evaluate the effect of crystalline forms of aripiprazole, an antipsychotic drug for
schizophrenia, on the dissolution rates and oral pharmacokinetics. Solubility, intrinsic …

Poor solubility and dissolution property of pharmaceuticals largely limits their bioavailability
and efficacy, and development of a multicomponent crystal is one of the effective …

Five novel cocrystals of antipsychotic drug aripiprazole are reported with dihydroxy-and
trihydroxybenzene coformers. The cocrystals are designed by exploiting the piperazine N …

A comprehensive characterization (thermal, spectroscopic, crystallographic, temperature-
and moisture-dependent stability, and transition characteristics) of solvates of aripiprazole …

Cocrystallization is an important route to tuning the solubility in drugs development,
including improving and reducing. Five cocrystals of aripiprazole (ARI) with resveratrol …